Study participants
All pediatric patients (<14 years old) with confirmed
hematology/oncology diagnoses and receiving high, moderate, low, and
minimum emetogenic chemotherapy regimens as inpatients or outpatients
were included in the study. We excluded patients with a history of
vomiting or those who had received any antiemetic medication 24 h prior
to commencement of chemotherapy.